Tissue-agnostic cancer drug
http://dbpedia.org/resource/Tissue-agnostic_cancer_drug
Tissue-agnostic cancer drugs are antineoplastic drugs that treat cancers based on the mutations that they display, instead of the tissue type in which they appear. Tissue-agnostic drugs that have been approved for medical use include Pembrolizumab, Larotrectinib, Selpercatinib, Entrectinib, and Pralsetinib.
rdf:langString
rdf:langString
Tissue-agnostic cancer drug
xsd:integer
59232788
xsd:integer
1086125362
rdf:langString
Tissue-agnostic cancer drugs are antineoplastic drugs that treat cancers based on the mutations that they display, instead of the tissue type in which they appear. Tissue-agnostic drugs that have been approved for medical use include Pembrolizumab, Larotrectinib, Selpercatinib, Entrectinib, and Pralsetinib.
xsd:nonNegativeInteger
6320